Method of treating a pathological syndrome and a pharmaceutical agent

Abstract

A method of treating a pathological syndrome includes administration of an activated form of ultra-low doses of antibodies to an antigen, wherein said activated form is obtained by repeated consecutive dilution combined with external impact, and the antigen is a substance or a pharmaceutical agent exerting influence upon the mechanisms of formation of this particular pathological syndrome. Pharmaceutical agent for treating a pathological syndrome contains activated form of ultra-low doses of monoclonal, polyclonal or natural antibodies to an antigen, wherein said activated form is prepared by means of repeated consecutive dilution and external treatment, predominantly based on homeopathic technology, and said antigen is a substance or a drug acting as a direct cause of the pathological syndrome or involved in regulation of mechanisms of its formation. At that, activated forms of ultra-low doses of antibodies are raised against antigens of exogenous or endogenous origin, against autologous antigens, fetal antigens; anti-idiotypic antibodies are used too.

1 - 16 . (canceled) 
     
     
         17 . A method of treating a disorder or condition of viral etiology, said method comprising administering to a patient in need thereof a homeopathically potentized form of an antibody to an antigen, which antigen is a molecule capable of treating or mitigating said disorder or condition of viral etiology. 
     
     
         18 . The method of  claim 17 , wherein said antigen is an endogenous biomolecule. 
     
     
         19 . The method of  claim 17 , wherein said antigen is an exogenous molecule. 
     
     
         20 . The method of  claim 19 , wherein said antigen is a hapten. 
     
     
         21 . The method of  claim 20 , wherein said hapten is a pharmaceutical molecule. 
     
     
         22 . The method of  claim 17 , wherein said antibody is selected from monoclonal, polyclonal and natural antibodies. 
     
     
         23 . The method of  claim 17 , wherein said homeopathically potentized form of an antibody is produced by homeopathic potentization. 
     
     
         24 . The method of  claim 18 , wherein said endogenous molecule is gamma interferon. 
     
     
         25 . The method of  claim 21  wherein the pharmaceutical molecule is selected from ciprofloxacin, metronidazole, maxinim, ciprobay, isoniazid, rifampicin, streptomycin, and paracetamol.